MYTERA 250 MG 120 TABLETS | Abiraterone Acetate Anti-Cancer Medicine
MYTERA 250 MG 120 TABLETS contain Abiraterone Acetate 250 mg, a prescription androgen biosynthesis inhibitor used in the treatment of metastatic prostate cancer under specialist medical supervision.
MYTERA 250 MG 120 TABLETS
MYTERA 250 MG TABLETS (Abiraterone Acetate 250 mg): Comprehensive Guide and Benefits
Introduction to MYTERA 250 MG TABLETS
Androgen Biosynthesis Inhibitor for Prostate Cancer
MYTERA 250 MG 120 TABLETS contain Abiraterone Acetate 250 mg, a prescription androgen biosynthesis inhibitor used in the treatment of metastatic prostate cancer. It works by reducing the production of androgens (male hormones), which can promote the growth of prostate cancer cells. Treatment is typically given under the supervision of an oncologist and is often used in combination with corticosteroid therapy.
Prescription Status: Prescription-only medicine. Use only under the supervision of a qualified oncology specialist.
Key Benefits of MYTERA 250 MG TABLETS
Helps reduce androgen production that fuels prostate cancer growth.
Supports the management of advanced and metastatic prostate cancer.
Oral treatment option for long-term therapy.
Can be used as part of a comprehensive oncology treatment plan.
Provides targeted hormonal therapy under specialist supervision.
Composition
Active Ingredient:
Abiraterone Acetate – 250 mg
Dosage Form:
Tablet
Pack Size:
Bottle of 120 Tablets
Drug Class
Androgen Biosynthesis Inhibitor
CYP17 (17α-hydroxylase/C17,20-lyase) Inhibitor
Therapeutic Category
Anticancer Medicine
Hormonal Therapy
How MYTERA 250 MG Works
Abiraterone Acetate inhibits the CYP17 enzyme, which is essential for androgen production in the testes, adrenal glands, and prostate tumor tissue. By lowering androgen levels, it helps slow the growth and progression of androgen-dependent prostate cancer.
Usage Instructions
Take MYTERA 250 MG TABLETS exactly as prescribed by your oncologist.
Swallow the tablets whole with water.
Take on an empty stomach, at least 1 hour before or 2 hours after food.
Take the medicine at the same time each day.
Continue treatment for the duration recommended by your healthcare provider.
Medicinal Advantages
Targeted Hormonal Therapy
Reduces androgen production to help slow prostate cancer progression.
Supports Advanced Prostate Cancer Management
Used as part of evidence-based treatment strategies for metastatic prostate cancer.
Convenient Oral Administration
Provides an oral alternative to injectable hormonal therapies.
Specialist-Supervised Treatment
Designed for long-term management under regular oncology monitoring.
Mechanism of Action
Abiraterone Acetate selectively blocks the CYP17 enzyme, preventing androgen synthesis. Reduced androgen levels deprive prostate cancer cells of hormonal stimulation, helping inhibit tumor growth.
Off-Label Uses
Healthcare professionals may prescribe Abiraterone Acetate for conditions outside its approved indications when clinically appropriate.
Expert Advice
Take the medicine exactly as prescribed.
Always take it on an empty stomach.
Attend regular follow-up appointments and laboratory monitoring.
Inform your doctor about all medicines and supplements you are taking.
Do not discontinue treatment without medical advice.
Precautions
Use only under specialist medical supervision.
Inform your doctor if you have liver disease, heart disease, or high blood pressure.
Regular monitoring of liver function, blood pressure, and blood potassium levels may be required.
This medicine is not intended for use during pregnancy or breastfeeding.
Storage Instructions
Store below 30°C.
Keep the tablets in the original container.
Protect from moisture and direct sunlight.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What is the active ingredient in MYTERA 250 MG TABLETS?
A: Each tablet contains Abiraterone Acetate 250 mg.
Q: What drug class does MYTERA 250 MG belong to?
A: MYTERA 250 MG belongs to the Androgen Biosynthesis Inhibitor (CYP17 Inhibitor) class of anticancer medicines.
Q: Should MYTERA 250 MG be taken with food?
A: No. It should be taken on an empty stomach, at least 1 hour before or 2 hours after food, as directed by your doctor.
Q: Is MYTERA 250 MG a prescription medicine?
A: Yes. MYTERA 250 MG TABLETS are prescription-only and should be used under the supervision of an oncology specialist.
Q: How should MYTERA 250 MG TABLETS be stored?
A: Store below 30°C in the original container, protected from moisture and direct sunlight.
Product Tags
MYTERA 250 MG 120 TABLETS, Abiraterone Acetate 250 mg, Androgen Biosynthesis Inhibitor, CYP17 Inhibitor, Hormonal Therapy, Prostate Cancer Medicine, Prescription Anticancer Medicine, Oncology Tablets.
